Consensus Cloud Solutions Inc Dossier - Source-backed chat

Consensus Cloud Solutions Inc

CCSINASDAQ

SectorInformation Technology

IndustryApplication Software

Beta (adjusted)1.60

Intrinsic Value $36.42median of 6 methods · middle span $29-$65based on filings through 30 Jun 2026

Market Price $35.73Price as of 1 Oct 2026

Near fair valueIntrinsic value is 2% above the market price

−50% · IV below pricenear fair value ±15%IV above price · +50%

Data confidence Sign in to view data confidence

Market Cap $654.7M

Enterprise Value $1.1B

Shares Outstanding 19M diluted

Moat Rating Wide

Next Earnings Date5 Nov 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Consensus Cloud Solutions, Inc. (CCSI) represents a compelling value opportunity in the secure information exchange and healthcare interoperability space. Following its spin-off from Ziff Davis in 2021, the company has successfully transitioned its focus from legacy SOHO (Small Office/Home Office) digital faxing to high-margin, sticky Corporate enterprise solutions. While the legacy SOHO business continues to experience a managed decline, the Corporate segment is accelerating, driven by native EHR integrations, FedRAMP High authorizations, and AI-powered document extraction tools (Clarity). With a robust adjusted EBITDA margin consistently exceeding 50% and strong free cash flow generation, CCSI is well-positioned to deleverage its balance sheet and execute its share repurchase program, making it highly undervalued at current trading multiples.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets4 analysts · as of 18 Aug 2026

Low · most bearish analyst$35.00

Mean target$38.00

High · most bullish analyst$42.00

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 19 Jun 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

SOHO segment churn accelerates rapidly, dragging down consolidated revenues. Corporate sales cycles lengthen due to macroeconomic pressures or increased competition from enterprise information management players. Margins compress due to aggressive pricing competition or increased marketing and personnel expenses required to drive corporate growth.

Base CaseCentral scenario

The Corporate segment continues its steady mid-to-high single-digit growth trajectory, supported by strong Net Revenue Retention (NRR) above 100% and expansion in regulated industries like healthcare and the public sector. SOHO segment declines are successfully managed and stabilized in the high single digits. Adjusted EBITDA margins remain stable within the 50%-55% target range. The company continues to utilize its free cash flow to opportunistically repurchase shares and reduce outstanding debt.

Bull CaseUpside scenario

Enterprise sales cycle accelerates past expectations, allowing CCSI to secure new client leads in the public sector (supported by success with VA contracts). Flattening SoHo revenue trajectory is offset by encouraging uptake of the Clarity AI platform among existing enterprise healthcare clients, driving positive market sentiment, higher ARPU opportunities, and valuation multiple re-rating.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits

Strong Corporate segment momentum with Q1 2026 revenue growth accelerating to 8.2% year-over-year.
High customer stickiness in regulated industries, reflected in a Net Revenue Retention (NRR) rate exceeding 102% in Q1 2026.
Industry-leading profitability with adjusted EBITDA margins consistently maintained in the 50% to 55% range.
Robust free cash flow generation ($38.5 million in Q1 2026) supporting active share buybacks and debt reduction.

Key Investment Risks

Continued revenue drag from the legacy SOHO segment, which declined 9.5% year-over-year in Q1 2026.
High leverage profile with significant outstanding senior notes, though actively managed through repurchases.
Intense competition in the secure document exchange and healthcare interoperability markets from larger players.

Thesis Invalidation Triggers

Corporate segment revenue growth decelerating below 5% for two consecutive quarters.
Net Revenue Retention (NRR) rate dropping below 100%, indicating loss of enterprise customer stickiness.
Adjusted EBITDA margin falling below the 50% threshold due to pricing pressure or cost overruns.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.